Nonalcoholic fatty liver diseases (NAFLD) represent a set of liver disorders progressing from
steatosis to steatohepatitis, fibrosis, cirrhosis, and hepatocellular carcinoma, which induce …

The effects of green tea (GT) in obese subjects have been evaluated in different studies, but
no consensus has been obtained due to the heterogeneity of the results. The dosage, the …

Background Dietary polyphenol treatment of non-alcoholic fatty liver disease (NAFLD) is a
novel direction, and the existing clinical studies have little effective evidence for its …

Fatty liver disease (FLD), including nonalcoholic fatty liver disease (NAFLD) and alcoholic
fatty liver disease (AFLD), is a serious chronic metabolic disease that affects a wide range of …

Abstract Non-Alcoholic Fatty Liver Disease (NAFLD) is a common condition affecting around
10–25% of the general adult population, 15% of children, and even> 50% of individuals who …

Nonalcoholic fatty liver disease (NAFLD), the most common chronic liver disease, is a
multifactorial disease resulting from the interaction between environment, genetic …

Nonalcoholic fatty liver disease (NAFLD) is a typical chronic liver disease highly correlated
with metabolic syndrome. Growing prevalence of NAFLD is supposed to be linked with the …

The therapeutic potential of green tea as a rich source of antioxidants and anti‐inflammatory
compounds has been investigated by several studies. The present study aimed to …

Summary Background & aims Beverages and Non-alcoholic fatty liver disease (NAFLD)
both the terms are associated with westernized diet and sedentary lifestyle. Throughout …

Purpose: A bulk of observational studies have revealed the protective role of green tea
supplementation in cardiovascular diseases. The current systematic review and meta …